Modulation of dopamine transmission by 5HT2c and 5HT3 receptors:: A role in the antidepressant response

被引:65
|
作者
Dremencov, E
Weizmann, Y
Kinor, N
Gispan-Herman, I
Yadid, G [1 ]
机构
[1] Bar Ilan Univ, Leslie Susan Gonda Goldschmied Multidisciplinary, IL-52900 Ramat Gan, Israel
[2] Bar Ilan Univ, Fac Life Sci, IL-52900 Ramat Gan, Israel
[3] Jerusalem Coll Technol, Dept Bioinformat, Jerusalem, Israel
[4] Univ Ottawa, Mental Hlth Res Inst, Ottawa, ON, Canada
关键词
animal model of depression; dopamine; Flinder Sensitive Line rats; nucleus accumbens; ventral striatum; nefazodone; mirtazapine; venlafaxine;
D O I
10.2174/138945006775515491
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Dopaminergic mesolimbic and mesocortical systems are fundamental in hedonia and motivation. Therefore their regulation should be central in understanding depression treatment. This review highlights the dopaminergic activity in relation to depressive behavior and suggests two putative receptors as potential targets for research and development of future antidepressants. In this article we review data that describe the role of serotonin in regulating dopamine release, via 5HT(2C) and 5HT(3) receptors. This action of serotonin appears to be linked to depressive-like behavior and to onset of behavioral effects of antidepressants in an animal model of depression. We suggest that drugs or strategies that decrease 5HT(2C) and increase 5HT(3) receptor-mediated dopamine release in the limbic areas of the brain may provide a fast onset of therapeutic effect. Clinical and basic research data supporting this hypothesis are discussed.
引用
收藏
页码:165 / 175
页数:11
相关论文
共 50 条
  • [41] Association of the 5HT2A and 5HT2C promoter polymorphisms with body mass index (BMI)
    Roberts, JE
    Wacker, MJ
    Tehel, MM
    Rosso, F
    McEchron, CA
    Donnelly, JE
    Godard, MP
    FASEB JOURNAL, 2005, 19 (05): : A1132 - A1132
  • [42] Endogenous angiotensin II and the reflex response to stimulation of cardiopulmonary serotonin 5HT3 receptors
    Veelken, R
    Hilgers, KF
    Scrogin, KE
    Mann, JFE
    Schmieder, RE
    BRITISH JOURNAL OF PHARMACOLOGY, 1998, 125 (08) : 1761 - 1767
  • [43] Aggression and anxiety in adolescent AAS-treated hamsters: A role for 5HT3 receptors
    Morrison, Thomas R.
    Ricci, Lesley A.
    Melloni, Richard H., Jr.
    PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR, 2015, 134 : 85 - 91
  • [44] A possible role for 5-HT2C receptors in postsynaptic feedback regulation of 5 HT neurones
    Raley, J. M.
    Boothman, L. B.
    Sharp, T.
    JOURNAL OF PHARMACOLOGICAL SCIENCES, 2006, 101 : 91 - 91
  • [45] Study of 5HT3 and 5HT4 Receptors Expression in HT29 Cell Line and Human Colon Adenocarcinoma Tissues
    Ataee, Ramin
    Ajdary, Soheila
    Rezayat, Mehdi
    Shokrgozar, Mohammad Ali
    Shahriari, Shadab
    Zarrindast, Mohammad Reza
    ARCHIVES OF IRANIAN MEDICINE, 2010, 13 (02) : 120 - 125
  • [46] Effects of 5-HT2 and 5-HT3 receptors on the modulation of nociceptive transmission in rat spinal cord according to the formalin test
    Sasaki, M
    Ishizaki, K
    Obata, H
    Goto, F
    EUROPEAN JOURNAL OF PHARMACOLOGY, 2001, 424 (01) : 45 - 52
  • [47] Role of presynaptic 5-HT1A and 5-HT3 receptors in modulation of synaptic GABA transmission in dissociated rat basolateral amygdala neurons
    Koyama, S
    Matsumoto, N
    Murakami, N
    Kubo, C
    Nabekura, J
    Akaike, N
    LIFE SCIENCES, 2002, 72 (4-5) : 375 - 387
  • [48] Role of 5-HT3 receptors in the mechanism of action of the investigational antidepressant vortioxetine
    Riga, M. S.
    Celada, P.
    Sanchez, C.
    Artigas, F.
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2013, 23 : S393 - S394
  • [49] SEROTONERGIC 5HT3 AND 5HT4 ACTIVITIES OF NOVEL AZATRICYCLIC AGENTS
    BECKER, DP
    FLYNN, DL
    NOSAL, R
    GULLIKSON, GW
    LOEFFLER, R
    MOUMI, C
    YANG, D
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 1991, 202 : 187 - MEDI
  • [50] Role of 5-HT1B, 5-HT2A and 5-HT2C receptors in the generalization of 5-HT receptor agonists to the ethanol cue in the rat
    Maurel, S
    Schreiber, R
    De Vry, J
    BEHAVIOURAL PHARMACOLOGY, 1998, 9 (04): : 337 - 343